Researchers at the Indian Institute of Science (IISc) have created a synthetic compound that mimics cancer cell antigens and can boost the immune system’s production of antibodies against cancer. This breakthrough offers a new strategy for developing cancer vaccines that target multiple types of cancer by modifying the antigen used.